生命科学分析市场规模、份额和成长分析：按组成部分、类型和地区 - 产业预测，2024-2031 年

2022年，全球生命科学分析市场规模将达到268亿美元，预测期内（2024-2031年）复合年增长率为11.4%，从2023年的298.6亿美元增加到2031年的701亿美元。成长到美国十亿美元。

由于医疗保健资料呈指数级增长以及对资料主导洞察的需求不断增长，生命科学分析市场正在经历快速增长。包括电子健康记录、基因组资料和现实世界证据在内的各种资料来源的融合正在为分析应用创建丰富的生态系统。透过利用人工智慧和机器学习等先进技术，生命科学公司可以释放宝贵的见解，以加速药物发现、优化临床试验并改善患者治疗结果。儘管资料隐私、整合和人才获取方面的挑战仍然存在，但在医疗保健产业对资料主导决策和创新的需求不断增长的推动下，生命科学分析的整体市场前景仍然乐观。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 市场成功的关键因素
• 竞争程度
• 关键投资机会
• 市场魅力指数
• 生态系绘图
• 技术分析
• 供应链分析
• 价值链分析
• 营运分析
• 专利分析
• 贸易分析
• 价格分析
• 使用案例分析
• Start-Ups分析
• 管道分析

生命科学分析市场：按类型

• 市场概况
• 概括
• 预测性的
• 规范的

生命科学分析市场：依组成部分

• 市场概况
• 软体
• 服务

生命科学分析市场：依分布

• 市场概况
• 本地交付模式
• 按需交付模式

生命科学分析市场：依应用分类

• 市场概况
• 研究与开发
  • 临床试验
  • 临床前测试
• 销售和行销
• 药物警戒
• 监理合规性
• 供应链优化

生命科学分析市场：依最终用户分类

• 市场概况
• 製药和生物技术公司
• 医疗设备公司
• 研究中心
• 第三方管理员

按地区分類的生命科学分析市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• ORACLE（US）
• IBM（US）
• SAS INSTITUTE INC.（US）
• ACCENTURE（Ireland）
• IQVIA INC.（US）
• COGNIZANT（US）
• WIPRO（India）
• ALLSCRIPTS HEALTHCARE, LLC（US）
• OPTUM, INC.（US）
• MICROSOFT（US）
• MAXISIT（US）
• EXLSERVICE HOLDINGS, INC.（US）
• CERNER CORPORATION（US）
• CITIUSTECH INC.（US）
• SAAMA TECHNOLOGIES, LLC（US）
• AXTRIA（US）
• CLARIVATE（UK）
• THOUGHTSPHERE（US）
• ALTERYX, INC.（US）
• SISENSE INC.（US）
• AMAZON WEB SERVICES, INC.（US）
• VEEVA SYSTEMS（US）

Global Life Science Analytics Market size was valued at USD 26.80 Billion in 2022 and is poised to grow from USD 29.86 Billion in 2023 to USD 70.10 Billion by 2031, at a CAGR of 11.4 % during the forecast period (2024-2031).

The life science analytics market is experiencing rapid growth fueled by the exponential increase in healthcare data and the growing need for data-driven insights. The convergence of various data sources, including electronic health records, genomic data, and real-world evidence, has created a rich ecosystem for analytics applications. By leveraging advanced technologies such as artificial intelligence and machine learning, life sciences organizations can extract valuable insights to accelerate drug discovery, optimize clinical trials, and improve patient outcomes. While challenges related to data privacy, integration, and talent acquisition persist, the overall market outlook for life science analytics remains positive, driven by the increasing demand for data-driven decision-making and innovation in the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Life Science Analytics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Life Science Analytics Market Segmental Analysis

The global life science analytics market is segmented on the basis of type, component, delivery, application, end-user and region. Based on type, the market is segmented into descriptive, predictive, and prescriptive. Based on component, the market is segmented into software, and services. In terms of delivery, the market is segmented into on-premise model, and on-demand model. By application, the market is segmented into research & development, preclinical trials, clinical trials, sales & marketing, regulatory compliance, supply chain optimization, pharmacovigilance. By end-user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Life Science Analytics Market

The growing utilization of real-world data (RWD) is revolutionizing the life sciences industry. By harnessing the power of electronic health records, wearables, and other data sources, organizations can gain valuable insights into patient populations, disease progression, and treatment effectiveness. RWD enables the development of more targeted therapies, accelerates drug development timelines, and supports evidence-based decision-making. As the volume and complexity of RWD continue to expand, advanced analytics and data management capabilities will be essential for unlocking its full potential.

Restraints in the Global Life Science Analytics Market

Data privacy and security are critical challenges in the life science analytics market. The handling of sensitive patient data requires stringent measures to protect information from unauthorized access, breaches, and misuse. Compliance with regulations like GDPR and HIPAA is essential to maintain patient trust and avoid legal repercussions. Organizations must invest in robust security infrastructure, implement data encryption and access controls, and adhere to strict data governance practices. Additionally, ensuring data quality and integrity is crucial for deriving accurate and reliable insights. By addressing these challenges, life science organizations can build trust with patients and stakeholders while maximizing the value of their data assets.

Market Trends of the Global Life Science Analytics Market

The demand for real-time analytics is rapidly increasing as organizations seek to gain a competitive edge and make data-driven decisions at the speed of business. By processing and analyzing data as it is generated, businesses can identify trends, patterns, and anomalies instantaneously, enabling timely interventions and optimized operations. This shift towards real-time insights is being driven by factors such as the increasing volume and velocity of data, the rise of IoT devices, and the need for rapid response to market changes. As technology continues to advance, real-time analytics is expected to become a critical capability for organizations across industries.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Technology Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Operational Analysis
• Patent Analysis
• Trade Analysis
• Pricing Analysis
• Use Case Analysis
• Startup Analysis
• Pipeline Analysis

Life Science Analytics Market by Type

• Market Overview
• Descriptive
• Predictive
• Prescriptive

Life Science Analytics Market by Component

• Market Overview
• Software
• Services

Life Science Analytics Market by Delivery

• Market Overview
• On-Premise Delivery Model
• On-Demand Delivery Model

Life Science Analytics Market by Application

• Market Overview
• Research & Development
  • Clinical Trials
  • Preclinical Trials
• Sales & Marketing
• Pharmacovigilance
• Regulatory Compliance
• Supply Chain Optimization

Life Science Analytics Market by End-User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Research Centers
• Third-party Administrators

Life Science Analytics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• ORACLE (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS INSTITUTE INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACCENTURE (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COGNIZANT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WIPRO (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALLSCRIPTS HEALTHCARE, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OPTUM, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROSOFT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MAXISIT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EXLSERVICE HOLDINGS, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CERNER CORPORATION (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CITIUSTECH INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAAMA TECHNOLOGIES, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AXTRIA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CLARIVATE (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• THOUGHTSPHERE (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALTERYX, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SISENSE INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMAZON WEB SERVICES, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VEEVA SYSTEMS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments